/

June 1, 2026

Seal of Excellence Highlights GLANCE’s Potential to Bring Advanced Single-Cell Analysis Closer to Clinical Research

GENIAL has received the Seal of Excellence for its GLANCE project proposal submitted under the WIDERA Pre-Accelerator programme.

The Seal of Excellence recognises the quality of the proposal and the innovation potential of GLANCE, GENIAL’s digital platform for the analysis of complex omics data in biomedical and clinical research. GLANCE is designed to make advanced omics data analysis more accessible, standardised, and efficient by bringing complex analytical workflows into an intuitive and collaborative environment. The platform supports reproducible data analysis, process traceability, and structured reporting, helping research teams manage complex datasets and generate biologically meaningful insights more efficiently.

This recognition represents an important milestone in the development of GLANCE and reinforces GENIAL’s efforts to advance the platform as a deep-tech solution supporting biomedical research, drug development, and precision medicine.